2002
DOI: 10.1016/s0378-5173(02)00028-5
|View full text |Cite
|
Sign up to set email alerts
|

Didanosine extended-release matrix tablets: optimization of formulation variables using statistical experimental design

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
24
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 69 publications
(25 citation statements)
references
References 11 publications
1
24
0
Order By: Relevance
“…A similar procedure can be used in formulation development to identify CPIs (material/intermediate attributes, manufacturing parameters, etc.) that influence the release profile of the product and which can be controlled to ensure final drug product quality (123,124).…”
Section: The Application Of Qbd Principles To Dissolution Methods Devementioning
confidence: 99%
“…A similar procedure can be used in formulation development to identify CPIs (material/intermediate attributes, manufacturing parameters, etc.) that influence the release profile of the product and which can be controlled to ensure final drug product quality (123,124).…”
Section: The Application Of Qbd Principles To Dissolution Methods Devementioning
confidence: 99%
“…Response Surface Methodology (RSM) is a collection of statistical and mathematical techniques useful for developing; improving and optimizing processes. There are different types of RSM designs, such as 3-level factorial design, central composite design (CCD) [14], Box-Behnken design [15], and Doptimal design [16]. RSM has been successfully utilized to optimize the compositions of microbiological media and improving solid state fermentation process [17].…”
Section: Research Papermentioning
confidence: 99%
“…1 However, active pharmaceutiexert the desired control of drug release from such systems. 2 From various reports on controlled-release systems published in the literature, [5][6][7][8][9][10][11][12] it is evident that at least 50% of the components in a tablet should be release-controlling polymers and other excipients and that the development of a formulation becomes very difficult, if not impossible, if at least 30-40% of the weight is not release-controlling polymers.…”
Section: Introductionmentioning
confidence: 99%